FDA Peptide Update: Category 2 Removals Explained FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) Peptide Therapy in Brandon & Lakeland, FL BPC 157, TB 500 & GHK Cu The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
bpc 157 fda classification Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides — BPC-157, TB-500, CJC-1295/Ipamorelin, AOD-9604, Epithalon, Selank, Semax. Others — like Sermorelin —